95 related articles for article (PubMed ID: 10674897)
1. CD40 and B chronic lymphocytic leukemia cell response to fludarabine: the influence of NF-kappaB/Rel transcription factors on chemotherapy-induced apoptosis.
Romano MF; Lamberti A; Turco MC; Venuta S
Leuk Lymphoma; 2000 Jan; 36(3-4):255-62. PubMed ID: 10674897
[TBL] [Abstract][Full Text] [Related]
2. Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells.
Romano MF; Lamberti A; Tassone P; Alfinito F; Costantini S; Chiurazzi F; Defrance T; Bonelli P; Tuccillo F; Turco MC; Venuta S
Blood; 1998 Aug; 92(3):990-5. PubMed ID: 9680368
[TBL] [Abstract][Full Text] [Related]
3. DHMEQ, a new NF-kappaB inhibitor, induces apoptosis and enhances fludarabine effects on chronic lymphocytic leukemia cells.
Horie R; Watanabe M; Okamura T; Taira M; Shoda M; Motoji T; Utsunomiya A; Watanabe T; Higashihara M; Umezawa K
Leukemia; 2006 May; 20(5):800-6. PubMed ID: 16525497
[TBL] [Abstract][Full Text] [Related]
4. The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine.
Hewamana S; Lin TT; Jenkins C; Burnett AK; Jordan CT; Fegan C; Brennan P; Rowntree C; Pepper C
Clin Cancer Res; 2008 Dec; 14(24):8102-11. PubMed ID: 19088025
[TBL] [Abstract][Full Text] [Related]
5. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
[TBL] [Abstract][Full Text] [Related]
6. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells.
Furman RR; Asgary Z; Mascarenhas JO; Liou HC; Schattner EJ
J Immunol; 2000 Feb; 164(4):2200-6. PubMed ID: 10657675
[TBL] [Abstract][Full Text] [Related]
7. Leflunomide induces apoptosis in fludarabine-resistant and clinically refractory CLL cells.
Dietrich S; Krämer OH; Hahn E; Schäfer C; Giese T; Hess M; Tretter T; Rieger M; Hüllein J; Zenz T; Ho AD; Dreger P; Luft T
Clin Cancer Res; 2012 Jan; 18(2):417-31. PubMed ID: 22072733
[TBL] [Abstract][Full Text] [Related]
8. Tipping the Noxa/Mcl-1 balance overcomes ABT-737 resistance in chronic lymphocytic leukemia.
Tromp JM; Geest CR; Breij EC; Elias JA; van Laar J; Luijks DM; Kater AP; Beaumont T; van Oers MH; Eldering E
Clin Cancer Res; 2012 Jan; 18(2):487-98. PubMed ID: 22128299
[TBL] [Abstract][Full Text] [Related]
9. Fludarabine induces apoptosis of human T-cell leukemia virus type 1-infected T cells via inhibition of the nuclear factor-kappaB signal pathway.
Nishioka C; Ikezoe T; Yang J; Koeffler HP; Taguchi H
Leukemia; 2007 May; 21(5):1044-9. PubMed ID: 17344917
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-kappa B/Rel-regulated inhibitors of apoptosis.
Munzert G; Kirchner D; Stobbe H; Bergmann L; Schmid RM; Döhner H; Heimpel H
Blood; 2002 Nov; 100(10):3749-56. PubMed ID: 12411322
[TBL] [Abstract][Full Text] [Related]
11. Dominant signals leading to inhibitor kappaB protein degradation mediate CD40 ligand rescue of WEHI 231 immature B cells from receptor-mediated apoptosis.
Schauer SL; Bellas RE; Sonenshein GE
J Immunol; 1998 May; 160(9):4398-405. PubMed ID: 9574544
[TBL] [Abstract][Full Text] [Related]
12. HuR Affects Proliferation and Apoptosis of Chronic Lymphocytic Leukemia Cells via NF-
Xiao K; Yang L; Gao X; An Y; Xie W; Jingquan G
Biomed Res Int; 2020; 2020():1481572. PubMed ID: 32908868
[TBL] [Abstract][Full Text] [Related]
13. The rate of in vitro fludarabine-induced peripheral blood and bone marrow cell apoptosis may predict the chemotherapy outcome in patients with chronic lymphocytic leukemia.
Podhorecka M; Klimek P; Chocholska S; Szymczyk A; Macheta A; Kowal M; Dmoszynska A; Hus M
Eur J Clin Pharmacol; 2015 Sep; 71(9):1121-7. PubMed ID: 26141594
[TBL] [Abstract][Full Text] [Related]
14. Role of Tumor Necrosis Factor-Producing Mesenchymal Stem Cells on Apoptosis of Chronic B-lymphocytic Tumor Cells Resistant to Fludarabine-based Chemotherapy.
Valizadeh A; Ahmadzadeh A; Saki G; Khodadadi A; Teimoori A
Asian Pac J Cancer Prev; 2015; 16(18):8533-9. PubMed ID: 26745113
[TBL] [Abstract][Full Text] [Related]
15. Preclinical assessment of curcumin as a potential therapy for B-CLL.
Everett PC; Meyers JA; Makkinje A; Rabbi M; Lerner A
Am J Hematol; 2007 Jan; 82(1):23-30. PubMed ID: 16947318
[TBL] [Abstract][Full Text] [Related]
16. Heat shock protein-90 inhibitor, NVP-AUY922, is effective in combination with fludarabine against chronic lymphocytic leukemia cells cultured on CD40L-stromal layer and inhibits their activated/proliferative phenotype.
Best OG; Mulligan SP
Leuk Lymphoma; 2012 Nov; 53(11):2314-20. PubMed ID: 22646928
[TBL] [Abstract][Full Text] [Related]
17. Targeting inhibitor of apoptosis proteins by Smac mimetic elicits cell death in poor prognostic subgroups of chronic lymphocytic leukemia.
Opel D; Schnaiter A; Dodier D; Jovanovic M; Gerhardinger A; Idler I; Mertens D; Bullinger L; Stilgenbauer S; Fulda S
Int J Cancer; 2015 Dec; 137(12):2959-70. PubMed ID: 26096065
[TBL] [Abstract][Full Text] [Related]
18. Maintenance of nuclear factor-kappa B/Rel and c-myc expression during CD40 ligand rescue of WEHI 231 early B cells from receptor-mediated apoptosis through modulation of I kappa B proteins.
Schauer SL; Wang Z; Sonenshein GE; Rothstein TL
J Immunol; 1996 Jul; 157(1):81-6. PubMed ID: 8683159
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic effect of fludarabine is independent of expression of IAPs in B-cell chronic lymphocytic leukemia.
Silva KL; Vasconcellos DV; Castro ED; Coelho AM; Linden R; Maia RC
Apoptosis; 2006 Feb; 11(2):277-85. PubMed ID: 16502265
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of cytosine arabinoside-induced apoptosis in human myeloblastic leukemia cells by NF-kappa B/Rel- specific decoy oligodeoxynucleotides.
Romano MF; Lamberti A; Bisogni R; Tassone P; Pagnini D; Storti G; Del Vecchio L; Turco MC; Venuta S
Gene Ther; 2000 Jul; 7(14):1234-7. PubMed ID: 10918492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]